KFDA painful to identify drug efficacy equivalency issue raised by civic groups.

Published: 1999-05-20 17:55:00

Updated: 1999-05-20 17:55:00

The definition of drug equivalent efficacy suggested by the civic group in connection with the latest proposal of the medical and pharmacy separation plan seems to be hardly acceptable to the KFDA and the pharmaceutical industry, and therefore they try to find out the real intention hidden inside...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK